Table 5.
Factors that influence HIV/AIDS clinical trial participation stratified by region and first language
| Characteristic | Total, N = 1992a |
Northeast (%) | Midwest (%) | South (%) | West (%) | Pb | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| E, n = 530 | S, n = 108 | E, n = 469 | S, n = 8 | E, n = 416 | S, n = 63 | E, n = 329 | S, n = 69 | |||
| Facilitators to participation | ||||||||||
| Help fight HIV/AIDS | 1629 (82) | 437 (82) | 73 (68) | 401 (86) | 3 (38) | 341 (82) | 41 (65) | 280 (85) | 53 (77) | <0.001 |
| Could receive better care | 756 (38) | 180 (34) | 48 (44) | 175 (37) | 1 (13) | 151 (36) | 37 (59) | 124 (38) | 40 (58) | <0.001 |
| Might get money | 612 (31) | 184 (35) | 22 (20) | 135 (29) | 1 (13) | 133 (32) | 10 (16) | 108 (33) | 19 (28) | 0.01 |
| More of my sex represented | 508 (26) | 154 (29) | 27 (25) | 107 (23) | 1 (13) | 106 (25) | 24 (38) | 67 (20) | 22 (32) | 0.02 |
| More of my race represented | 519 (26) | 150 (28) | 33 (31) | 106 (23) | 1 (13) | 114 (27) | 28 (44) | 58 (18) | 29 (42) | <0.001 |
| Provider recommended | 761 (38) | 180 (34) | 38 (35) | 181 (39) | 1 (13) | 153 (37) | 32 (51) | 151 (46) | 25 (36) | 0.01 |
| Barriers to participation | ||||||||||
| Worry about a placebo | 328 (16) | 75 (14) | 8 (7) | 90 (19) | 0 (0) | 55 (13) | 14 (22) | 74 (22) | 12 (17) | <0.001 |
| Worry my information would be revealed | 375 (19) | 89 (17) | 12 (11) | 111 (24) | 2 (25) | 80 (19) | 16 (25) | 50 (15) | 15 (22) | 0.01 |
| Do not understand studies | 160 (8) | 36 (7) | 14 (13) | 32 (7) | 1 (13) | 50 (12) | 7 (11) | 14 (4) | 6 (9) | 0.003 |
Only responses with statistically significant P values are included in table. AIDS, acquired immunodeficiency syndrome; E, English; HIV, human immunodeficiency virus; S, Spanish.
a
Respondents who did not report a first language (n = 102) or who reported other languages (n = 31) were not included in analysis.
b
P values from χ2 test of independence.